[HTML][HTML] Molecular pathology of human papilloma virus-negative cervical cancers
H Yoshida, K Shiraishi, T Kato - Cancers, 2021 - mdpi.com
Simple Summary Although cervical cancer is mainly caused by infection with human
papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative …
papillomavirus (HPV), some cervical cancers test negative for HPV. As these HPV-negative …
[HTML][HTML] Applications of FAPI PET/CT in the diagnosis and treatment of breast and the most common gynecologic malignancies: a literature review
T Li, J Zhang, Y Yan, M Tan, Y Chen - Frontiers in Oncology, 2024 - frontiersin.org
The fibroblast activating protein (FAP) is expressed by some fibroblasts found in healthy
tissues. However, FAP is overexpressed in more than 90% of epithelial tumors, including …
tissues. However, FAP is overexpressed in more than 90% of epithelial tumors, including …
[HTML][HTML] The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models
M Ye, T Liu, L Miao, S Zou, H Ji, J Zhang, X Zhu - Cancers, 2023 - mdpi.com
Simple Summary Zinc finger protein 275 (ZNF275) is a C2H2-type transcription factor
localized on chromosome Xq28. The present study indicated that cervical cancer tissue …
localized on chromosome Xq28. The present study indicated that cervical cancer tissue …
[HTML][HTML] Establishment and genetically characterization of patient-derived xenograft models of cervical cancer
S Zou, M Ye, J Zhang, H Ji, Y Chen, X Zhu - BMC Medical Genomics, 2022 - Springer
Purpose Patient-derived xenograft (PDX) models were established to reproduce the clinical
situation of original cancers and have increasingly been applied to preclinical cancer …
situation of original cancers and have increasingly been applied to preclinical cancer …
[HTML][HTML] Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer
Z Lu, P Fan, W Huo, Y Feng, R Wang - Translational Oncology, 2024 - Elsevier
Objective This study aimed to investigate the genomic alteration profiles of cervical cancer
patients, examine the correlation between mutation patterns and clinical and immune …
patients, examine the correlation between mutation patterns and clinical and immune …
RNA modification “writer”-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer
Y Qu, H Zhu, C Kong, X Zheng, D Wang… - Clinical and …, 2022 - Springer
Purpose As an epigenetic regulation mechanism after transcription, RNA modification is
installed by endogenous" writer" enzymes and is widely involved in a variety of physiological …
installed by endogenous" writer" enzymes and is widely involved in a variety of physiological …
Integrative Multi-Omics Approaches for Identifying Cervical Cancer Therapeutic Targets
SK Duppala, R Yadala, A Velingkar, P Suravajhala… - bioRxiv, 2022 - biorxiv.org
After breast cancer, cervical cancer (CC) is one of the most common malignancies in women
globally. Over 90% of chronic infections are caused by human papillomavirus (HPV) and its …
globally. Over 90% of chronic infections are caused by human papillomavirus (HPV) and its …
[HTML][HTML] Prognostic models for predicting overall and cancer-specific survival of patients with initially diagnosed metastatic cervical squamous cell carcinoma: A study …
R Ding, Z Su, M Chen, L Chen - Medicine, 2023 - journals.lww.com
Cervical squamous cell carcinoma (CSCC) is the most common histological type of cervical
cancer (CC). And mCSCC is the end stage of CSCC. The aim of this study was to develop …
cancer (CC). And mCSCC is the end stage of CSCC. The aim of this study was to develop …
LncRNA799/TBL1XR1/ZEB1 axis forms a feedback loop to promote the epithelial-mesenchymal transition of cervical cancer cells
L Liao, P Huang, J Zhao, Z Wang… - Critical Reviews™ in …, 2024 - dl.begellhouse.com
Cervical cancer is a common malignancy among women worldwide. Long non-coding RNAs
(lncRNAs) are frequently involved in the pathogenesis of cervical cancer. Therefore, the …
(lncRNAs) are frequently involved in the pathogenesis of cervical cancer. Therefore, the …
Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent …
M Ao, P Li, D Sun, X Li, S Xu, Y Hao - Journal of Obstetrics and …, 2023 - Taylor & Francis
The current study sought to investigate the effect of nimotuzumab combined with concurrent
chemoradiotherapy (CCRT+ Nim) on T lymphocyte subsets in middle-advanced CC. Firstly …
chemoradiotherapy (CCRT+ Nim) on T lymphocyte subsets in middle-advanced CC. Firstly …